logo image
search icon
 Global Autoinjectors Market

Autoinjector Market Size, Share & Trends Analysis Report By Type of Autoinjector (Disposable and Reusable), Route of Administration (Subcutaneous and Intramuscular), Type of Molecule (Monoclonal Antibody, Peptide, Protein, and Small Molecule), Therapeutic Indication, Region And Segment Forecasts, 2023-2031.

Report ID : 1234 | Published : 2023-10-03 | Pages: 180 | Format: PDF/EXCEL

The Autoinjector Market Size is valued at 1000.0 Million in 2023 and is predicted to reach 3085.4 Million by the year 2031 at a 15.1 % CAGR during the forecast period for 2023-2031.

Autoinjector Market

Autoinjectors are pen-like devices that deliver a fixed dose of medication to a patient and are meant to be self-administered. Autoinjectors are gradually becoming the gold standard in the treatment of anaphylaxis, multiple sclerosis, and rheumatoid arthritis. The majority of autoinjectors are spring-loaded, and self-injection is a simple technique. These devices can assist patients in preventing needle stick injuries and lessen needle fear. To improve the simplicity of use and alleviate the anxiety associated with self-administration of intramuscular injections, autoinjector manufacturers are focused on user-centric approaches. The autoinjector market is expected to grow significantly, given the rise in anaphylactic cases. Furthermore, firms' increased R&D efforts to create simple, cost-effective, and innovative technology-based autoinjectors for the treatment of chronic diseases such as rheumatoid arthritis and multiple sclerosis are likely to fuel market growth throughout the forecast period.

On the other hand, there are a variety of chronic conditions that necessitate daily injections. The illness's diversity, on the other hand, requires a combination of autoinjector requirements. The injection capacity, dosage, length, and thickness must be varied for each medication. Different types of autoinjectors result from these factors. The absence of appropriate autoinjectors and product variety may have a negative impact on the autoinjector business. The OEM is untrained in the production of several medications. The major players are addressing these market problems. The market is attempting to meet this problem by conducting additional research.

Market Segmentation:

The Global Autoinjectors Market is segmented on the basis of Type of Autoinjector, Route of Administration, Type of Molecule, Therapeutic Indication. Type of Autoinjector segment includes Disposable and Reusable, Route of Administration segment includes Subcutaneous and Intramuscular, Type of Molecule segment includes Monoclonal Antibody, Peptide, Protein, and Small Molecule, Therapeutic Indication segment includes Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis, Migraine, Diabetes)

Based on Therapeutic Indication, rheumatoid arthritis is accounted as a significant contributor to the Global Autoinjectors Market.

In 2021, the market for autoinjectors was dominated by rheumatoid arthritis (RA). The high prevalence of this group accounts for its significant share, and the rising prevalence of RA is driving up demand for autoinjectors in this treatment area. Arthritis, RA, gout, lupus, and fibromyalgia affect an estimated 20% of the total population in the United States each year.

 

In The Region, The North America Global Autoinjectors Market Holds A Significant Revenue Share.

The Asia Pacific market is expected to outperform other regional players during the projected period. In this area, autoinjectors are in high demand. The rising number of diabetics is driving up demand for the product. Furthermore, the healthcare infrastructure is growing at a breakneck speed, and it leads to an increase in the production of autoinjectors. In this region, home care and self-administration of chronic conditions rise. Many patients and their families learn to use autoinjectors for non-urgent situations. The existence of leading autoinjector firms is beneficial to market growth. In the Asia-Pacific area, autoinjectors are constantly evolving and in high demand. Furthermore, an increase in the occurrences of anaphylaxis, rheumatoid arthritis, and other disorders such as anaemia and migraine and future technological developments by firms are likely to propel the market forward.

To keep and grow their customer base, key players are focusing on portable and user-friendly auto-injectors. To protect their brand equity, companies like Mylan N.V. and Eli Lilly and Company are focusing more on user-friendly auto-injectors. New entrants are concentrating their efforts on reaching emerging markets by introducing low-cost auto-injector devices. Some businesses, such as Mylan N.V., Teva Pharmaceuticals, and others, are launching generic versions of cost-effective auto-injectors devices and targeting emerging markets, such as Asia-Pacific, the Middle East, and others, in order to stay competitive and grow in the global Auto-Injectors Market.

Competitive Landscape

Some of The Key Players in The Autoinjector Market:

  • Antares Pharma, Inc.

  •  

    Becton, Dickinson and Company (BD)

  •  

    Bespak

  •  

    DALI Medical Device

  •  

    Elcam Medical

  •  

    Haselmeier GmbH

  •  

    Jiangsu Delfu medical device

  •  

    Kaleo, Inc.

  •  

    Oval Medical Technologies Ltd.

  •  

    Owen Mumford Ltd.

  •  

    Pharma Consult

  •  

    Philip-Medisize, LLC

  •  

    Recipharm AB

  •  

    SHL Medical

  •  

    Solteam Incorporation Co., Ltd.

  •  

    Union Medico

  •  

    West Pharmaceutical Services, Inc.

  •  

    Ypsomed Holding AG.

  •  

    AktiVax

  •  

    Amneal Pharmaceuticals

  •  

    Nemera

  •  

    Nuance Designs

  •  

    Windgap Medical

  •  

    Xeris Pharmaceuticals

  •  

    Zion Clinical Pharmacy

The Autoinjector Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 1090.0 Million

Revenue Forecast In 2031

USD 3085.4 Million

Growth Rate CAGR

CAGR of 15.1 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Type of Autoinjector, Route of Administration, Type of Molecule, Therapeutic Indication

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Amgen Inc., Antares Pharma, Becton, Dickinson, And Company (BD), ELI LILLY AND COMPANY, Johnson & Johnson, MYLAN N.V., Novartis AG, SHL MEDICAL AG, TEVA Pharmaceutical Industries LTD., YPSOMED AG, ATS Automation Tooling Systems Inc. Owen Mumford Ltd., SHL Group, Oval Medical Technologies Ltd., E3D Elcam Drug Delivery Devices, kaleo, Inc., Crossject, Gerresheimer AG.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Autoinjectors Market Snapshot

Chapter 4. Global Autoinjectors Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. COVID 19 Impact Analysis 2020

Chapter 5. Market Segmentation 1: Type Estimates & Trend Analysis

5.1. Type & Market Share, 2020 & 2028

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2028 for the following Type:

5.2.1. Disposable autoinjectors

5.2.2. Reusable autoinjectors

Chapter 6. Market Segmentation 2: Applications & Trend Analysis

6.1. Applications & Market Share, 2020 & 2028

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2028 for the following Applications:

6.2.1. Rheumatoid Arthritis

6.2.2. Anaphylaxis

6.2.3. Multiple Sclerosis

6.2.4. Others

Chapter 7. Market Segmentation 3: End-Users & Trend Analysis

7.1. End-Users & Market Share, 2020 & 2028

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2020 to 2028 for the following End-Users:

7.2.1. Home care settings

7.2.2. Hospitals & Clinics

Chapter 8. Autoinjectors Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts Type, 2020-2028

8.1.2. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2020-2028

8.1.3. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2020-2028

8.1.4. North America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2020-2028

8.1.4.1. U.S.

8.1.4.2. Canada

8.2. Europe

8.2.1. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) Type, 2020-2028

8.2.2. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2020-2028

8.2.3. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2020-2028

8.2.4. Europe Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2028

8.2.4.1. Germany

8.2.4.2. Poland

8.2.4.3. France

8.2.4.4. Italy

8.2.4.5. Spain

8.2.4.6. UK

8.2.4.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) Type, 2020-2028

8.3.2. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2020-2028

8.3.3. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2020-2028

8.3.4. Asia Pacific Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2028

8.3.4.1. China

8.3.4.2. India

8.3.4.3. Japan

8.3.4.4. Australia

8.3.4.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) Type, 2020-2028

8.4.2. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2020-2028

8.4.3. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2020-2028

8.4.4. Latin America Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2028

8.4.4.1. Brazil

8.4.4.2. Rest of Latin America

8.5. MEA

8.5.1. MEA Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts Type, 2020-2028

8.5.2. MEA Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Applications, 2020-2028

8.5.3. MEA Autoinjectors Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts End-Users, 2020-2028

8.5.4. MEA revenue Autoinjectors Market revenue (US$ Million) and volume (No. of Units) by country, 2020-2028

8.5.4.1. South Africa

8.5.4.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles 

9.2.1. Amgen Inc.

9.2.2. Antares Pharma

9.2.3. Becton, Dickinson, And Company (BD)

9.2.4. ELI LILLY AND COMPANY

9.2.5. Johnson & Johnson

9.2.6. MYLAN N.V.

9.2.7. Novartis AG

9.2.8. SHL MEDICAL AG

9.2.9. TEVA Pharmaceutical Industries LTD.

9.2.10. YPSOMED AG

9.2.11. ATS Automation Tooling Systems Inc.

9.2.12. Owen Mumford Ltd.

9.2.13. SHL Group

9.2.14. Oval Medical Technologies Ltd.

9.2.15. E3D Elcam Drug Delivery Devices

9.2.16. kaleo, Inc.

9.2.17. Crossject

9.2.18. Gerresheimer AG

Segmentation of Global Autoinjectors Market-

By Type-

  • Disposable Autoinjectors
  • Reusable Autoinjectors

Autoinjector Market

By Type of Molecule-

  • Monoclonal Antibody
  • Peptide
  • Protein
  • Small Molecule

By Therapeutic Indication-

  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Migraine
  • Diabetes
  • Others

By Route of Administration-

  • Subcutaneous
  • Intramuscular

By End-Users-

  • Home care settings
  • Hospitals & Clinics

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

Who are the Key Players in the Global Autoinjectors Market?

The Autoinjector Market Size is valued at 1000.0 Million in 2023 and is predicted to reach 3085.4 Million by the year 2031.

The Autoinjector Market is expected to grow at a 15.1 % CAGR during the forecast period for 2023-2031.

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach